Edward Connor, MD, MBE, FAAP

Dr. Connor (Clinical Research Alliance, LLC) is Executive Director and Scientific Lead for the Pediatric Trials Consortium at the Critical Path Institute and Emeritus Professor of Pediatrics, Microbiology, Immunology and Tropical Medicine at George Washington University and Children’s National Health System. He holds an MD and Masters Degree in Bioethics from the Perelman School of Medicine at the University of Pennsylvania and did postgraduate training in Pediatrics at Northwestern and Pediatric Infectious Diseases at the University of Rochester. He has more than 30 years of experience in drug and biologics development in academia and the biotechnology industry. He was PI of the Pediatric AIDS Clinical Trials Unit at New Jersey Medical School, Chairman of the national NIAID-ACTG Pediatric Research Committee, and PI of ACTG 076 that led to FDA approval of zidovudine for prevention of mother-to-infant transmission of HIV. Dr. Connor served as an advisor to NIH, FDA, CDC, WHO and other authorities and led initial efforts to establish standards of care for HIV-infected children and pregnant women.

Subsequently Dr. Connor was the Executive Vice President and Chief Medical Officer at MedImmune, directing clinical development programs, including ones leading to regulatory approval of products for prevention of serious Respiratory Syncytial Virus disease and a live attenuated intranasal influenza vaccine. He was also responsible for Medical Affairs, Product Safety, and Clinical Operations, including Biostatistics/Data Management and was Co-Chair of the company’s product development committee. In 2008, Dr. Connor returned to academia as Director of the Office of Innovation Development at Children’s National Health System; Professor of Pediatrics, Microbiology, Immunology and Tropical Medicine at George Washington University School of Medicine and Health Sciences; and member of the executive team at the Clinical and Translational Science Institute at Children’s National in Washington DC.